Enzo Biochem
ENZ
$1.09
Share price
-1.80%
Change (1 day)
-54.77%
Change (1 year)
Categories
P/S ratio for Enzo Biochem (ENZ)
P/S ratio as of May 2024 (TTM): 4.36
According to Enzo Biochem's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.36015. At the end of 2024 the company had a P/S ratio of 5.01.
P/S ratio history for Enzo Biochem from 2001 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 5.01 | -14.14% |
| 2023 | 5.83 | 390.31% |
| 2022 | 1.19 | -17.54% |
| 2021 | 1.44 | 39.78% |
| 2020 | 1.03 | -44.98% |
| 2019 | 1.88 | 16.24% |
| 2018 | 1.61 | -62.15% |
| 2017 | 4.26 | 56.87% |
| 2016 | 2.72 | 55.35% |
| 2015 | 1.75 | -27.63% |
| 2014 | 2.42 | 116.86% |
| 2013 | 1.11 | 46.1% |
| 2012 | 0.7630 | -29.41% |
| 2011 | 1.08 | -35.88% |
| 2010 | 1.69 | -24.3% |
| 2009 | 2.23 | -18.02% |
| 2008 | 2.72 | -62.18% |
| 2007 | 7.18 | -37.61% |
| 2006 | 11.5 | 13.43% |
| 2005 | 10.1 | -26.26% |
| 2004 | 13.8 | 11.74% |
| 2003 | 12.3 | 72.29% |
| 2002 | 7.15 | -27.11% |
| 2001 | 9.81 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | 1.73 | -60.40% | 🇺🇸 USA |
 LabCorp LH | 1.44 | -66.90% | 🇺🇸 USA |
 RadNet RDNT | 2.63 | -39.78% | 🇺🇸 USA |
 Psychemedics PMD | 0.6778 | -84.45% | 🇺🇸 USA |
 NeoGenomics
NEO | 3.10 | -29.01% | 🇺🇸 USA |
 Qiagen QGEN | 5.23 | 19.91% | 🇳🇱 Netherlands |